(Hypertension. 1996;27:760-765.)
© 1996 American Heart Association, Inc.
Articles |
Opposing Actions of Angiotensin II on Microvascular Growth and Arterial Blood Pressure
From the Department of Physiology, Medical College of Wisconsin, Milwaukee.
Correspondence to Andrew S. Greene, PhD, Department of Physiology, Medical College of Wisconsin, 8701 Watertown Plank Rd, Milwaukee, WI 53226. E-mail agreene@mcw.edu.
Abstract We performed studies to further elucidate the mechanisms of angiotensin II (Ang II)–induced angiogenesis of the microvasculature. Rats were placed on a high salt diet (4% NaCl), and Ang II was infused at a subpressor rate (5 ng/kg per minute) for 3 days. Blood pressure was measured daily for 2 control and 3 infusion days. Microvessel density in the cremaster muscle was measured at the end of the infusion. Vessel density in rats that received subpressor Ang II infusion increased by 12.6% compared with rats that received vehicle infusion. When the angiotensin type 2 (AT2) receptor antagonist PD 123319 was coinfused with Ang II, blood pressure was elevated and vessel density increased above that observed with Ang II infusion alone (23% increase). When the AT1 receptor antagonist losartan was coinfused with Ang II, blood pressure was lower than control and vessel density was reduced compared with the Ang II group but was still greater than control (7.8% increase). In this study, Ang II stimulated angiogenesis in the rat cremaster muscle; this effect was enhanced by AT2 antagonism and inhibited by AT1 antagonism. Ang II infusion at a subpressor dose resulted in a pressor response with AT2 antagonism and a depressor response with AT1 antagonism. This suggests that in the microvasculature, the AT1 receptor mediates angiogenesis and vasoconstriction, and the AT2 receptor mediates an inhibition of angiogenesis and vasodilation.
Key Words: receptors, angiotensin • angiotensin • angiogenesis • losartan • receptors, angiotensin II, PD 123319
This article has been cited by other articles:
 |
|
 |
|
  Y. Suarez and W. C. Sessa MicroRNAs As Novel Regulators of Angiogenesis Circ. Res., February 27, 2009; 104(4): 442 - 454. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Belabbas, S. Zalvidea, D. Casellas, J.-P. Moles, O. Galbes, J. Mercier, and B. Jover Contrasting effect of exercise and angiotensin II hypertension on in vivo and in vitro cardiac angiogenesis in rats Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2008; 295(5): R1512 - R1518. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. de Resende, S. L. Amaral, C. Moreno, and A. S. Greene Congenic strains reveal the effect of the renin gene on skeletal muscle angiogenesis induced by electrical stimulation Physiol Genomics, October 8, 2008; 33(1): 33 - 40. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. de Resende and A. S. Greene Effect of ANG II on endothelial cell apoptosis and survival and its impact on skeletal muscle angiogenesis after electrical stimulation Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2814 - H2821. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P Collister and D. B Nahey Changing dietary sodium alters the chronic cardiovascular effects of losartan in rats Journal of Renin-Angiotensin-Aldosterone System, March 1, 2008; 9(1): 10 - 16. [Abstract] [PDF]
|
|
|
|
 |
|
 P. Li, T. Kondo, Y. Numaguchi, K. Kobayashi, M. Aoki, N. Inoue, K. Okumura, and T. Murohara Role of Bradykinin, Nitric Oxide, and Angiotensin II Type 2 Receptor in Imidapril-Induced Angiogenesis Hypertension, February 1, 2008; 51(2): 252 - 258. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Kai Chen, D. C. Merrill, and J. C. Rose The Importance of Angiotensin II Subtype Receptors for Blood Pressure Control During Mouse Pregnancy Reproductive Sciences, October 1, 2007; 14(7): 694 - 704. [Abstract] [PDF]
|
|
|
|
|
|
K. Rakusan, Z. Chvojkova, P. Oliviero, I. Ostadalova, F. Kolar, C. Chassagne, J.-L. Samuel, and B. Ostadal ANG II type 1 receptor antagonist irbesartan inhibits coronary angiogenesis stimulated by chronic intermittent hypoxia in neonatal rats Am J Physiol Heart Circ Physiol, March 1, 2007; 292(3): H1237 - H1244. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. K. Mehta and K. K. Griendling Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system Am J Physiol Cell Physiol, January 1, 2007; 292(1): C82 - C97. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Feihl, L. Liaudet, B. Waeber, and B. I. Levy Hypertension: A Disease of the Microcirculation? Hypertension, December 1, 2006; 48(6): 1012 - 1017. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ushio-Fukai Redox signaling in angiogenesis: Role of NADPH oxidase Cardiovasc Res, July 15, 2006; 71(2): 226 - 235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Petersen, D. H. Munzenmaier, and A. S. Greene Angiotensin II infusion restores stimulated angiogenesis in the skeletal muscle of rats on a high-salt diet Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H114 - H120. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. de Resende, S. L. Amaral, D. H. Munzenmaier, and A. S. Greene Role of endothelial cell apoptosis in regulation of skeletal muscle angiogenesis during high and low salt intake Physiol Genomics, April 13, 2006; 25(2): 325 - 335. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. H. Munzenmaier and A. S. Greene Chronic angiotensin II AT1 receptor blockade increases cerebral cortical microvessel density Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H512 - H516. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D'Amore, M. J. Black, and W. G. Thomas The Angiotensin II Type 2 Receptor Causes Constitutive Growth of Cardiomyocytes and Does Not Antagonize Angiotensin II Type 1 Receptor-Mediated Hypertrophy Hypertension, December 1, 2005; 46(6): 1347 - 1354. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Zheng, I. M. Bird, D.-B. Chen, and R. R. Magness Angiotensin II regulation of ovine fetoplacental artery endothelial functions: interactions with nitric oxide J. Physiol., May 15, 2005; 565(1): 59 - 69. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Duke, R. G. Evans, and R. E Widdop AT2 receptors contribute to acute blood pressure-lowering and vasodilator effects of AT1 receptor antagonism in conscious normotensive but not hypertensive rats Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2289 - H2297. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Forder, D. H. Munzenmaier, and A. S. Greene Angiogenic protection from focal ischemia with angiotensin II type 1 receptor blockade in the rat Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1989 - H1996. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Vazquez, I. Coronel, R. Bautista, E. Romo, C. M. Villalon, M. C. Avila-Casado, V. Soto, and B. Escalante Angiotensin II-dependent induction of AT2 receptor expression after renal ablation Am J Physiol Renal Physiol, January 1, 2005; 288(1): F207 - F213. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. I. Levy Can Angiotensin II Type 2 Receptors Have Deleterious Effects in Cardiovascular Disease?: Implications for Therapeutic Blockade of the Renin-Angiotensin System Circulation, January 6, 2004; 109(1): 8 - 13. [Full Text] [PDF]
|
|
|
|
 |
|
 H. Thai, J. Wollmuth, S. Goldman, and M. Gaballa Angiotensin Subtype 1 Receptor (AT1) Blockade Improves Vasorelaxation in Heart Failure by Up-Regulation of Endothelial Nitric-Oxide Synthase via Activation of the AT2 Receptor J. Pharmacol. Exp. Ther., December 1, 2003; 307(3): 1171 - 1178. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Uemura, H. Ishiguro, N. Nakaigawa, Y. Nagashima, Y. Miyoshi, K. Fujinami, A. Sakaguchi, and Y. Kubota Angiotensin II receptor blocker shows antiproliferative activity in prostate cancer cells: A possibility of tyrosine kinase inhibitor of growth factor Mol. Cancer Ther., November 1, 2003; 2(11): 1139 - 1147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Benndorf, R. H. Boger, S. Ergun, A. Steenpass, and T. Wieland Angiotensin II Type 2 Receptor Inhibits Vascular Endothelial Growth Factor-Induced Migration and In Vitro Tube Formation of Human Endothelial Cells Circ. Res., September 5, 2003; 93(5): 438 - 447. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Sarlos, B. Rizkalla, C. J. Moravski, Z. Cao, M. E. Cooper, and J. L. Wilkinson-Berka Retinal Angiogenesis Is Mediated by an Interaction between the Angiotensin Type 2 Receptor, VEGF, and Angiopoietin Am. J. Pathol., September 1, 2003; 163(3): 879 - 887. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Yuan, M. Liang, Z. Yang, E. Rute, N. Taylor, M. Olivier, and A. W. Cowley Jr. Gene expression reveals vulnerability to oxidative stress and interstitial fibrosis of renal outer medulla to nonhypertensive elevations of ANG II Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2003; 284(5): R1219 - R1230. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Shimizu, H. Okamoto, S. Chiba, Y. Matsui, T. Sugawara, M. Akino, J. Nan, H. Kumamoto, H. Onozuka, T. Mikami, et al. VEGF-mediated angiogenesis is impaired by angiotensin type 1 receptor blockade in cardiomyopathic hamster hearts Cardiovasc Res, April 1, 2003; 58(1): 203 - 212. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. de Boer, Y. M. Pinto, A. J.H. Suurmeijer, S. Pokharel, E. Scholtens, M. Humler, J. M. Saavedra, F. Boomsma, W. H. van Gilst, and D. J. van Veldhuisen Increased expression of cardiac angiotensin II type 1 (AT1) receptors decreases myocardial microvessel density after experimental myocardial infarction Cardiovasc Res, February 1, 2003; 57(2): 434 - 442. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Loufrani, B. I. Levy, and D. Henrion Defect in Microvascular Adaptation to Chronic Changes in Blood Flow in Mice Lacking the Gene Encoding for Dystrophin Circ. Res., December 13, 2002; 91(12): 1183 - 1189. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Rueckschloss, M. T. Quinn, J. Holtz, and H. Morawietz Dose-Dependent Regulation of NAD(P)H Oxidase Expression by Angiotensin II in Human Endothelial Cells: Protective Effect of Angiotensin II Type 1 Receptor Blockade in Patients With Coronary Artery Disease Arterioscler. Thromb. Vasc. Biol., November 1, 2002; 22(11): 1845 - 1851. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Jesmin, Y. Hattori, I. Sakuma, C. N. Mowa, and A. Kitabatake Role of ANG II in coronary capillary angiogenesis at the insulin-resistant stage of a NIDDM rat model Am J Physiol Heart Circ Physiol, October 1, 2002; 283 (4): H1387 - H1397. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-S. Silvestre, R. Tamarat, T. Senbonmatsu, T. Icchiki, T. Ebrahimian, M. Iglarz, S. Besnard, M. Duriez, T. Inagami, and B. I. Levy Antiangiogenic Effect of Angiotensin II Type 2 Receptor in Ischemia-Induced Angiogenesis in Mice Hindlimb Circ. Res., May 31, 2002; 90(10): 1072 - 1079. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Schuijt, P. R. Saxena, A.H. J. Danser, R. M. Carey, N. L. Howell, X.-H. Jin, and H. M. Siragy No Net Effect of Angiotensin II on Blood Pressure? * Response Hypertension, May 1, 2002; 39 (5): e27 - e28. [Full Text] [PDF]
|
|
|
|
|
|
R. Tamarat, J.-S. Silvestre, N. Kubis, J. Benessiano, M. Duriez, M. deGasparo, D. Henrion, and B. I. Levy Endothelial Nitric Oxide Synthase Lies Downstream From Angiotensin II-Induced Angiogenesis in Ischemic Hindlimb Hypertension, March 1, 2002; 39(3): 830 - 835. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Stoll, A. W.A. Hahn, U. Jonas, Y. Zhao, B. Schieffer, J. W. Fischer, and T. Unger Identification of a Zinc Finger Homoeodomain Enhancer Protein After AT2 Receptor Stimulation by Differential mRNA Display Arterioscler. Thromb. Vasc. Biol., February 1, 2002; 22(2): 231 - 237. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Berry, R. Touyz, A. F. Dominiczak, R. C. Webb, and D. G. Johns Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2337 - H2365. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Schuijt, M. Basdew, R. van Veghel, R. de Vries, P. R. Saxena, R. G. Schoemaker, and A. H. Jan Danser AT2 receptor-mediated vasodilation in the heart: effect of myocardial infarction Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2590 - H2596. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.H. Schauser, A.H. Nielsen, H. Winther, V. Dantzer, and K. Poulsen Localization of the Renin-Angiotensin System in the Bovine Ovary: Cyclic Variation of the Angiotensin II Receptor Expression Biol Reprod, December 1, 2001; 65(6): 1672 - 1680. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Carey, N. L. Howell, X.-H. Jin, and H. M. Siragy Angiotensin Type 2 Receptor-Mediated Hypotension in Angiotensin Type-1 Receptor-Blocked Rats Hypertension, December 1, 2001; 38(6): 1272 - 1277. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Deinum, J. M.G. van Gool, M. J.M. Kofflard, F. J. ten Cate, and A.H. J. Danser Angiotensin II Type 2 Receptors and Cardiac Hypertrophy in Women With Hypertrophic Cardiomyopathy Hypertension, December 1, 2001; 38(6): 1278 - 1281. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Henrion, N. Kubis, and B. I. Levy Physiological and Pathophysiological Functions of the AT2 Subtype Receptor of Angiotensin II: From Large Arteries to the Microcirculation Hypertension, November 1, 2001; 38(5): 1150 - 1157. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Amaral, P. E. Papanek, and A. S. Greene Angiotensin II and VEGF are involved in angiogenesis induced by short-term exercise training Am J Physiol Heart Circ Physiol, September 1, 2001; 281(3): H1163 - H1169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W Fischer, M. Stoll, A. W.A Hahn, and T. Unger Differential regulation of thrombospondin-1 and fibronectin by angiotensin II receptor subtypes in cultured endothelial cells Cardiovasc Res, September 1, 2001; 51(4): 784 - 791. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S. Weber and J. H. Lombard Angiotensin II AT1 receptors preserve vasodilator reactivity in skeletal muscle resistance arteries Am J Physiol Heart Circ Physiol, May 1, 2001; 280(5): H2196 - H2202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. F. Moore, N. T. Heiderstadt, E. Huang, N. L. Howell, Z.-Q. Wang, H. M. Siragy, and R. M. Carey Selective Inhibition of the Renal Angiotensin Type 2 Receptor Increases Blood Pressure in Conscious Rats Hypertension, May 1, 2001; 37(5): 1285 - 1291. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Saavedra, W. Hauser, G. Ciuffo, G. Egidy, K.-L. Hoe, O. Johren, T. Sembonmatsu, T. Inagami, and I. Armando Increased AT1 receptor expression and mRNA in kidney glomeruli of AT2 receptor gene-disrupted mice Am J Physiol Renal Physiol, January 1, 2001; 280(1): F71 - F78. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. FLISER, R. DIKOW, S. DEMUKAJ, and E. RITZ Opposing Effects of Angiotensin II on Muscle and Renal Blood Flow under Euglycemic Conditions J. Am. Soc. Nephrol., November 1, 2000; 11(11): 2001 - 2006. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. de Gasparo, K. J. Catt, T. Inagami, J. W. Wright, and Th. Unger International Union of Pharmacology. XXIII. The Angiotensin II Receptors Pharmacol. Rev., September 1, 2000; 52(3): 415 - 472. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. R. Nurkiewicz and M. A. Boegehold Reinforcement of arteriolar myogenic activity by endogenous ANG II: susceptibility to dietary salt Am J Physiol Heart Circ Physiol, July 1, 2000; 279(1): H269 - H278. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Engeli, R. Negrel, and A. M. Sharma Physiology and Pathophysiology of the Adipose Tissue Renin-Angiotensin System Hypertension, June 1, 2000; 35(6): 1270 - 1277. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Gallinat, S. Busche, M. K. Raizada, and C. Sumners The angiotensin II type 2 receptor: an enigma with multiple variations Am J Physiol Endocrinol Metab, March 1, 2000; 278(3): E357 - E374. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. B. Parker, A. D. Dobrian, S. S. Wade, and R. L. Prewitt AT1 receptor inhibition does not reduce arterial wall hypertrophy or PDGF-A expression in renal hypertension Am J Physiol Heart Circ Physiol, February 1, 2000; 278(2): H613 - H622. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Carey, Z.-Q. Wang, and H. M. Siragy Role of the Angiotensin Type 2 Receptor in the Regulation of Blood Pressure and Renal Function Hypertension, January 1, 2000; 35(1): 155 - 163. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Chamoux Involvement of the Angiotensin II Type 2 Receptor in Apoptosis during Human Fetal Adrenal Gland Development J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4722 - 4730. [Abstract] [Full Text]
|
|
|
|
|
|
X. RUAN, M. I. OLIVERIO, T. M. COFFMAN, and W. J. ARENDSHORST Renal Vascular Reactivity in Mice: AngII-Induced Vasoconstriction inAT1A Receptor Null Mice J. Am. Soc. Nephrol., December 1, 1999; 10(12): 2620 - 2630. [Abstract] [Full Text]
|
|
|
|
|
|
T. J. Bivalacqua, A. Dalal, H. C. Champion, and P. J. Kadowitz Role of AT1 receptors and autonomic nervous system in mediating acute pressor responses to ANG II in anesthetized mice Am J Physiol Endocrinol Metab, November 1, 1999; 277(5): E838 - E847. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. N. Barber, D. B. Sampey, and R. E. Widdop AT2 Receptor Stimulation Enhances Antihypertensive Effect of AT1 Receptor Antagonist in Hypertensive Rats Hypertension, November 1, 1999; 34(5): 1112 - 1116. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Cote, T. H. Do, L. Laflamme, J.-M. Gallo, and N. Gallo-Payet Activation of the AT2 Receptor of Angiotensin II Induces Neurite Outgrowth and Cell Migration in Microexplant Cultures of the Cerebellum J. Biol. Chem., October 29, 1999; 274(44): 31686 - 31692. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Gendron*, L. Laflamme*, N. Rivard, C. Asselin, M. D. Payet, and N. Gallo-Payet Signals from the AT2 (Angiotensin Type 2) Receptor of Angiotensin II Inhibit p21ras and Activate MAPK (Mitogen-Activated Protein Kinase) to Induce Morphological Neuronal Differentiation in NG108-15 Cells Mol. Endocrinol., September 1, 1999; 13(9): 1615 - 1626. [Abstract] [Full Text]
|
|
|
|
|
|
J.-E. Fabre, A. Rivard, M. Magner, M. Silver, and J. M. Isner Tissue Inhibition of Angiotensin-Converting Enzyme Activity Stimulates Angiogenesis In Vivo Circulation, June 15, 1999; 99(23): 3043 - 3049. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Tritto and G. Ambrosio Spotlight on microcirculation: an update Cardiovasc Res, June 1, 1999; 42(3): 600 - 606. [Full Text] [PDF]
|
|
|
|
|
|
M. Horiuchi, M. Akishita, and V. J. Dzau Recent Progress in Angiotensin II Type 2 Receptor Research in the Cardiovascular System Hypertension, February 1, 1999; 33(2): 613 - 621. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Tamura, Y. Wanaka, E. J. Landon, and T. Inagami Intracellular Sodium Modulates the Expression of Angiotensin II Subtype 2 Receptor in PC12W Cells Hypertension, February 1, 1999; 33(2): 626 - 632. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. H. Nora, D. H. Munzenmaier, F. M. Hansen-Smith, J. H. Lombard, and A. S. Greene Localization of the ANG II type 2 receptor in the microcirculation of skeletal muscle Am J Physiol Heart Circ Physiol, October 1, 1998; 275(4): H1395 - H1403. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.J.M. G. Nelissen-Vrancken, M. C. Kuizinga, M. J.A.P. Daemen, and J. F.M. Smits Early captopril treatment inhibits DNA synthesis in endothelial cells and normalization of maximal coronary flow in infarcted rat hearts Cardiovasc Res, October 1, 1998; 40(1): 156 - 164. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Lucius, S. Gallinat, P. Rosenstiel, T. Herdegen, J. Sievers, and T. Unger The Angiotensin II Type 2 (AT2) Receptor Promotes Axonal Regeneration in the Optic Nerve of Adult Rats J. Exp. Med., August 17, 1998; 188(4): 661 - 670. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Muthalif, I. F. Benter, M. R. Uddin, J. L. Harper, and K. U. Malik Signal Transduction Mechanisms Involved in Angiotensin-(1-7)-Stimulated Arachidonic Acid Release and Prostanoid Synthesis in Rabbit Aortic Smooth Muscle Cells J. Pharmacol. Exp. Ther., January 1, 1998; 284(1): 388 - 398. [Abstract] [Full Text]
|
|
|
|
|
|
D. Fliser, F. Schaefer, D. Schmid, J. D. Veldhuis, and E. Ritz Angiotensin II Affects Basal, Pulsatile, and Glucose-Stimulated Insulin Secretion in Humans Hypertension, November 1, 1997; 30(5): 1156 - 1161. [Abstract] [Full Text]
|
|
|
|
|
|
M. J. Rieder, R. Carmona, J. E. Krieger, K. A. Pritchard Jr, and A. S. Greene Suppression of Angiotensin-Converting Enzyme Expression and Activity by Shear Stress Circ. Res., March 1, 1997; 80(3): 312 - 319. [Abstract] [Full Text]
|
|
|
|
|
|
L. Xu and V. L. Brooks Sodium Intake, Angiotensin II Receptor Blockade, and Baroreflex Function in Conscious Rats Hypertension, January 1, 1997; 29(1): 450 - 457. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Gohlke, I. Kuwer, A. Schnell, K. Amann, G. Mall, and T. Unger Blockade of Bradykinin B2 Receptors Prevents the Increase in Capillary Density Induced by Chronic Angiotensin-Converting Enzyme Inhibitor Treatment in Stroke-Prone Spontaneously Hypertensive Rats Hypertension, January 1, 1997; 29(1): 478 - 482. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. H. Messerli, M. A. Weber, and H. R. Brunner Angiotensin II Receptor Inhibition: A New Therapeutic Principle Arch Intern Med, September 23, 1996; 156(17): 1957 - 1965. [Abstract] [PDF]
|
|
|
|
|
|
J.-S. Silvestre, S. Bergaya, R. Tamarat, M. Duriez, C. M. Boulanger, and B. I. Levy Proangiogenic Effect of Angiotensin-Converting Enzyme Inhibition Is Mediated by the Bradykinin B2 Receptor Pathway Circ. Res., October 12, 2001; 89(8): 678 - 683. [Abstract] [Full Text] [PDF]
|
|